Livzon Pharmaceutical Group's market cap is currently $4.00B. The company's EPS TTM is $0.304; its P/E ratio is 11.27; and it has a dividend yield of 5.58%. Livzon Pharmaceutical Group is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $0.06. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 12.43B	¥ 12.63B	¥ 12.06B	¥ 10.52B	¥ 9.38B
Gross Profit	¥ 7.66B	¥ 8.17B	¥ 7.81B	¥ 6.85B	¥ 5.99B
Operating Income	¥ 2.42B	¥ 2.35B	¥ 2.27B	¥ 2.50B	¥ 1.73B
EBITDA	¥ 3.33B	¥ 3.08B	¥ 2.77B	¥ 2.91B	¥ 2.12B
Net Income	¥ 1.95B	¥ 1.91B	¥ 1.78B	¥ 1.71B	¥ 1.30B
Balance Sheet
Cash & Short-Term Investments	¥ 11.41B	¥ 10.52B	¥ 9.33B	¥ 9.98B	¥ 8.87B
Total Assets	¥ 25.04B	¥ 24.86B	¥ 22.37B	¥ 20.59B	¥ 17.98B
Total Debt	¥ 3.48B	¥ 3.62B	¥ 2.69B	¥ 1.93B	¥ 1.36B
Net Debt	¥ -7.84B	¥ -6.79B	¥ -6.45B	¥ -8.02B	¥ -7.49B
Total Liabilities	¥ 10.28B	¥ 9.93B	¥ 8.06B	¥ 6.95B	¥ 5.70B
Stockholders' Equity	¥ 14.04B	¥ 13.88B	¥ 13.00B	¥ 12.11B	¥ 11.17B
Cash Flow
Free Cash Flow	¥ 2.43B	¥ 1.83B	¥ 593.23M	¥ 1.51B	¥ 1.37B
Operating Cash Flow	¥ 3.25B	¥ 2.77B	¥ 1.90B	¥ 2.16B	¥ 1.77B
Investing Cash Flow	¥ -708.37M	-	-	-	¥ -316.02M
Financing Cash Flow	-	-	-	-	-

Currency in CNY

Livzon Pharmaceutical Group Earnings and Revenue History

Income Statement >

Livzon Pharmaceutical Group Debt to Assets

Balance Sheet >

Livzon Pharmaceutical Group Cash Flow

Cash Flow >

Livzon Pharmaceutical Group Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing